PosiSep X
Commercial- Indications
- Sinus surgery hemostasis
Company intelligence / Profile preview
Hemostasis, LLC is a private medical device company specializing in the design and manufacture of advanced bleeding control technologies. Its portfolio includes topical powders, sponges, patches, dressings, and drug delivery devices for surgical and emergency use. The company’s products are marketed under brands such as Accel, NexStat, BoneSeal, PosiSep, Vectra F, NexPak, BleedArrest. These products are used across various clinical settings to manage moderate to severe bleeding efficiently. The company is active with an estimated $5.9 million revenue in 2024 and about 40 employees.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemostasis.